Gemcitabine and carboplatin induction chemotherapy followed by concurrent cisplatin and IMRT for locally advanced nasopharyngeal cancer

Phase 1

Recruiting

• Conditions: ocally advanced nasopharyngeal cancer; Locally advanced nasopharyngeal cancer; Cancer - Head and neck

• Registration Number: ACTRN12605000509662
• Lead Sponsor: Peter MacCallum Cancer Centre

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2005-09-26
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

WHO types 2 and 3 nasopharyngeal cancer; T3-4 and/or N1 > 3 cm, N2-3; no prior malignancies, no prior chemotherapy or radiation

Exclusion Criteria

No exclusion criteria

Study & Design

• Study Type: Interventional
• Study Design: Not specified